SEVRE-LONG caps ret 60 mg 30 pce

7680539520380 CH-53952 N02AA01 01.01.3.
SEVRE-LONG caps ret 60 mg 30 pce
SEVRE-LONG caps ret 60 mg 30 pce
SEVRE-LONG caps ret 60 mg 30 pce
1 / 3
google

Details

Product number
5395202
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
morphini sulfas pentahydricus 60 mg corresp. morphinum 45.12 mg, oleum vegetabile hydrogenatum, macrogolum 6000, talcum, magnesii stearas, Kapselhülle: E 132, E 172 (rubrum), E 172 (flavum), E 171, natrii laurilsulfas corresp. natrium 0.008 mg, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.

Articles (1)

Sevre-Long 60 mg, Kapseln retard
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/05/2025
Professional SmPC
Français
13/05/2025
Professional SmPC
Italien
13/05/2025
Patient information leaflet
Allemand
16/10/2024
Patient information leaflet
Français
16/10/2024
Patient information leaflet
Italien
16/10/2024

Detailed composition

Substance Quantity Type Category
morphini sulfas pentahydricus
60.0 MG Substance WIZUS
morphinum
45.12 MG Substance Wirkstoff (Principe actif)
oleum vegetabile hydrogenatum
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
E 132
- Substance FIMDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 171
- Substance FNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.008 MG Substance HBESI
gelatina
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 52.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2002

Authorization holder

Mundipharma Medical Company,

4052 Basel

Authorization information

Swissmedic authorization number
53952
Drug name
Sevre-Long, Kapseln retard
Galenic form
RETH
ATC Code
N02AA01
Authorization status
Z
Dispensation category
A+
First authorization
30/01/1997
Authorization expiration date
31/12/9999
IT number
01.01.3.
Domain
Human medicine
Field of application
Opioides Analgetikum, Substitutionsbehandlung bei Opioidabhängigkeit

Packaging details

Description (FR)
SEVRE-LONG caps ret 60 mg 30 pce
Description (DE)
SEVRE-LONG Ret Kaps 60 mg 30 Stk
Market launch
30/01/1997
Narcotic (BTM)
A

Other packaging sizes

SEVRE-LONG caps ret 30 mg 30 pce
30 KAP
GTIN: 7680539520113
View
SEVRE-LONG caps ret 120 mg 100 pce
100 KAP
GTIN: 7680539520014
View
SEVRE-LONG caps ret 120 mg 30 pce
30 KAP
GTIN: 7680539520465
View
SEVRE-LONG caps ret 200 mg 100 pce
100 KAP
GTIN: 7680539520021
View
SEVRE-LONG caps ret 200 mg 30 pce
30 KAP
GTIN: 7680539520540
View
Buy us a coffee Explore the data